{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?uin=HL2187", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?uin=HL2187", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?uin=HL2187&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&uin=HL2187", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?uin=HL2187", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?uin=HL2187", "items" : [{"_about" : "http://data.parliament.uk/resources/1687665", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1687665/answer", "answerText" : {"_value" : "
The National Institute for Health and Care Excellence (NICE) has not yet made a recommendation for managed access under the Innovative Medicines Fund (IMF), and so the fund has been used exclusively for interim funding to accelerate patient access to medicines recommended by NICE for routine commissioning. To date, four medicines have received interim funding through the IMF.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2024-02-09", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-02-09T12:26:41.453Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-02-05", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Innovative Medicines Fund"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what is the breakdown of utilisation of the Innovative Medicines Fund for (1) interim funding for medicines recommended by the National Institute for Health and Care Excellence, and (2) managed access, since June 2022.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2024", "label" : {"_value" : "Biography information for Lord Hunt of Kings Heath"} } , "tablingMemberPrinted" : [{"_value" : "Lord Hunt of Kings Heath"} ], "uin" : "HL2187"} , {"_about" : "http://data.parliament.uk/resources/1504869", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1504869/answer", "answerText" : {"_value" : "
There are currently no plans to do so. However, the UK National Screening Committee is due to review the evidence for prostate cancer screening in 2023.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4582", "label" : {"_value" : "Biography information for Baroness Bloomfield of Hinton Waldrist"} } , "answeringMemberPrinted" : {"_value" : "Baroness Bloomfield of Hinton Waldrist"} , "dateOfAnswer" : {"_value" : "2022-09-26", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2022-09-26T13:21:46.773Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2022-09-05", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Prostate Cancer: Screening"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what plans they have to introduce an NHS national screening programme for prostate cancer.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1796", "label" : {"_value" : "Biography information for Lord Taylor of Warwick"} } , "tablingMemberPrinted" : [{"_value" : "Lord Taylor of Warwick"} ], "uin" : "HL2187"} , {"_about" : "http://data.parliament.uk/resources/1348868", "AnsweringBody" : [{"_value" : "Foreign, Commonwealth and Development Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1348868/answer", "answerText" : {"_value" : "
The UK remains extremely concerned by the appalling human rights situation in North Korea, as we made clear alongside G7 leaders on 13 June and G7 Foreign and Development Ministers on 5 May. The international community has a responsibility to respond to human rights violations in North Korea. The UK continues to press for annual debate in the UN Security Council on DPRK human rights issues. We welcome and support the annual Human Rights Council and UNGA Third Committee resolutions on human rights in North Korea which stress the importance of following up recommendations from the UN Commission of Inquiry Report on Human Rights in the DPRK, and provide the basis for further work on a credible framework for accountability for human rights violations in the country.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4210", "label" : {"_value" : "Biography information for Lord Ahmad of Wimbledon"} } , "answeringMemberPrinted" : {"_value" : "Lord Ahmad of Wimbledon"} , "dateOfAnswer" : {"_value" : "2021-07-30", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-07-30T13:30:24.747Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "208"} , "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "date" : {"_value" : "2021-07-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "North Korea: Crimes against Humanity"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what assessment they have made of the impact on the international rule of law and the authority of the United Nations of the non-implementation of the recommendation of the 2014 UN Commission of Inquiry to refer evidence of crimes against humanity in North Korea to the UN Security Council for investigation by the International Criminal Court.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/738", "label" : {"_value" : "Biography information for Lord Alton of Liverpool"} } , "tablingMemberPrinted" : [{"_value" : "Lord Alton of Liverpool"} ], "uin" : "HL2187"} , {"_about" : "http://data.parliament.uk/resources/1182485", "AnsweringBody" : [{"_value" : "Cabinet Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1182485/answer", "answerText" : {"_value" : "
Records of Government contracts above £10,000 in central government and £25,000 in the wider public sector are published on Contracts Finder:<\/p>